Does ADALIMUMAB Cause Nephrolithiasis? 2,416 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 2,416 reports of Nephrolithiasis have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.5% of all adverse event reports for ADALIMUMAB.
2,416
Reports of Nephrolithiasis with ADALIMUMAB
0.5%
of all ADALIMUMAB reports
28
Deaths
1,213
Hospitalizations
How Dangerous Is Nephrolithiasis From ADALIMUMAB?
Of the 2,416 reports, 28 (1.2%) resulted in death, 1,213 (50.2%) required hospitalization, and 18 (0.7%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 2,416 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Nephrolithiasis?
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
PREDNISONE (694)
Which ADALIMUMAB Alternatives Have Lower Nephrolithiasis Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB